ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2018, Vol. 27 ›› Issue (4): 358-363.DOI: 10.3969/j.issn.1006-298X.2018.04.014

• 论文 • 上一篇    下一篇

肾癌的手术治疗及残余肾功能评估与保护

  

  • 出版日期:2018-08-28 发布日期:2018-08-31

Evaluation and preservation of residual renal function after cancer nephrectomy

  • Online:2018-08-28 Published:2018-08-31

摘要:

随着医学影像学技术发展及人口老龄化加剧,肾癌诊断率显著增加。多数肾癌患者仍首选手术治疗,包括根治性肾切除术和部分肾切除术。肾癌术后慢性肾脏病(CKD)风险增加。CKD是心血管疾病和死亡的高危因素,肾癌术后残余肾功能(RRF)的保护应受到重视。研究表明,根治性肾切除是早期肾癌术后CKD发生及进展的危险因素,此外,患者的基线肾功能、蛋白尿、非肿瘤性肾实质异常病理改变、肿瘤分期、人口学特征、并发症(糖尿病、高血压等)及术中热缺血时间等因素也与术后CKD相关。因此,在达到等效抗肿瘤效应的同时,如何更好地评估和保护肾癌术后RRF,有待进一步认识和提高。

关键词: 肾癌, 肾切除术, 残余肾功能, 慢性肾脏病

Abstract:

With the advancements in diagnostic technology and longer life expectancies,the incidence of renal carcinoma is increasing.Surgical resection remains the goldstandard treatment for renal cancer,including radical nephrectomy and partial nephrectomy,while the risk of newonset or accelerated chronic kidney disease(CKD) after nephrectomy increased.As CKD is an independent risk factor for cardiovascular disease and death,residual renal function(RRF)after nephrectomy got valued.Studies shown that radical nephrectomy increased the risk of adverse renal outcome,as well as the baseline renal function,proteinuria,intrinsic abnormalities in nonneoplastic renal parenchyma,tumor stage,demographics,comorbid conditions (such as diabetes mellitus,hypertension),warm ischemia and other factors.Therefore,it needs further understanding and improvement to better evaluate and preserve the RRF postnephrectomy when achieve oncological outcomes.

Key words: renal cancer, nephrectomy, residual renal function, chronic kidney disease